Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > EU to propose easing medicines flow from Britain to Northern Ireland
    Top Stories

    EU to propose easing medicines flow from Britain to Northern Ireland

    Published by maria gbaf

    Posted on December 17, 2021

    2 min read

    Last updated: January 28, 2026

    Featured image depicting Elon Musk's growing influence over financial probes as U.S. investigations into his business practices intensify. This image highlights the intersection of finance and regulatory challenges Musk faces.
    Elon Musk's influence on US finance probes amid regulatory chaos - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    The EU plans to propose changes to ease the transport of medicines from Britain to Northern Ireland, addressing potential post-Brexit disruptions.

    EU to Propose Changes for Medicines Flow to Northern Ireland

    BRUSSELS (Reuters) – The European Commission is due to set out on Friday legal changes to ease the transport of medicines from Britain to Northern Ireland, a move that could relieve EU-UK tensions over the British province’s future after Brexit.

    The flow of medicines is currently unimpeded, but set to change when a grace period expires at the end of the year.

    Then British operators would need to move regulatory compliance and logistics and testing facilities to the European Union or to Northern Ireland, which is part of the United Kingdom but within the EU single market for goods.

    The cost of the move could result in certain companies deciding to stop supplying medicines to Northern Ireland, exacerbating trading problems the province is facing after Brexit.

    The EU executive is set to propose an exception to existing law to allow compliance and logistics to be located in the British mainland.

    The change could also benefit other smaller markets – Cyprus, Ireland and Malta – that have traditionally received certain medicines from Britain.

    A further change, solely for Northern Ireland, could allow marketing of drugs in Northern Ireland after they have been authorised by the British medicines regulator, but before approval from the European Medicines Agency.

    This move could, for example, affect new cancer treatments.

    The Commission declined to comment on the substance of any proposals.

    The changes, which would require approval by the European Parliament and EU governments during 2022, do not represent a formal agreement with Britain on the subject.

    It has advocated removing medicines entirely from the protocol that sets out the post-Brexit trading arrangements of Northern Ireland and a renegotiation of the protocol itself.

    The EU has offered a package of measures https://www.reuters.com/world/europe/whats-eu-plan-future-britain-to-nireland-trade-2021-10-13 designed to ease transit of goods to Northern Ireland.

    (Reporting by Philip Blenkinsop; Editing by Alison Williams)

    Key Takeaways

    • •EU to propose legal changes for medicine transport to Northern Ireland.
    • •Current unimpeded flow set to change post-grace period.
    • •Proposal could benefit smaller markets like Cyprus, Ireland, Malta.
    • •Changes require approval by European Parliament and EU governments.
    • •EU aims to ease post-Brexit trading issues with Northern Ireland.

    Frequently Asked Questions about EU to propose easing medicines flow from Britain to Northern Ireland

    1What is the main topic?

    The EU's proposal to ease the transport of medicines from Britain to Northern Ireland to address post-Brexit issues.

    2What changes are proposed?

    Legal changes to allow compliance and logistics to remain in Britain, benefiting Northern Ireland and other smaller markets.

    3Who needs to approve the changes?

    The European Parliament and EU governments need to approve the proposed changes.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostU.S. curbs Chinese drone maker DJI, other firms it accuses of aiding rights abuses
    Next Top Stories PostCDC recommends Moderna, Pfizer COVID-19 vaccines over J&J’s